Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Nuray Bilge

Showing results (11-20 of 19) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 19 results.
Neurology India|January 9, 2026
Restless Leg Syndrome and Association with Serum NT Pro-CNPReyhan Yuksek, Mustafa Ceylan, Nuray Bilge, et al.
Journal of Electrocardiology|January 27, 2019
Evaluation of ventricular repolarization parameters during migraine attacksMustafa Öztürk, Oğuzhan Ekrem Turan, Kayıhan Karaman, et al.
Multiple Sclerosis and Related Disorders|September 24, 2025
Impact of age at onset on diagnosis, treatment, and prognosis in pediatric-onset multiple sclerosis: A multicenter study from TurkeyOzlem Ethemoglu, Nuray Bilge, Meral Seferoğlu, et al.
Multiple Sclerosis and Related Disorders|April 30, 2026
Beyond serology: clinical and prognostic determinants in patients with dual AQP4-IgG and MOG-IgG seropositivityIpek Gungor Dogan, Sedat Sen, Damla Cetinkaya Tezer, et al.
Neurological Sciences : Official Journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology|June 6, 2025
Characteristics of pain in patients with NMOSD and MOGAD: impact on mental health, sleep and quality of lifeEmine Rabia Koc, Furkan Saridas, Mehmet Fatih Yetkin, et al.
Multiple Sclerosis and Related Disorders|February 9, 2024
The role of oligoclonal band count and IgG index in treatment response and disease activity in multiple sclerosisEsra Taşkıran, Murat Terzi, Elif Merve Helvacı, et al.
Noro Psikiyatri Arsivi|March 13, 2023
Clinical and Demographic Characteristics and Two-Year Efficacy and Safety Data of 508 Multiple Sclerosis Patients with Fingolimod TreatmentMurat Terzi, Elif Merve Helvacı, Sedat Şen, et al.
Journal of Neuroimmunology|July 22, 2025
Comparative efficacy of rituximab versus azathioprine in the treatment of MOG antibody-associated disease (MOGAD)Sedat Şen, Murat Kürtüncü, Serkan Demir, et al.
Balkan Medical Journal|June 3, 2024
Clinical, Demographic, and Radiological Characteristics of Patients Demonstrating Antibodies Against Myelin Oligodendrocyte GlycoproteinSümeyye Koç, Sedat Şen, Yüksel Terzi, et al.
Pageof 2

Showing results (11-20 of 19) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 19 results.
Neurology India|January 9, 2026
Restless Leg Syndrome and Association with Serum NT Pro-CNPReyhan Yuksek, Mustafa Ceylan, Nuray Bilge, et al.
Journal of Electrocardiology|January 27, 2019
Evaluation of ventricular repolarization parameters during migraine attacksMustafa Öztürk, Oğuzhan Ekrem Turan, Kayıhan Karaman, et al.
Multiple Sclerosis and Related Disorders|September 24, 2025
Impact of age at onset on diagnosis, treatment, and prognosis in pediatric-onset multiple sclerosis: A multicenter study from TurkeyOzlem Ethemoglu, Nuray Bilge, Meral Seferoğlu, et al.
Multiple Sclerosis and Related Disorders|April 30, 2026
Beyond serology: clinical and prognostic determinants in patients with dual AQP4-IgG and MOG-IgG seropositivityIpek Gungor Dogan, Sedat Sen, Damla Cetinkaya Tezer, et al.
Neurological Sciences : Official Journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology|June 6, 2025
Characteristics of pain in patients with NMOSD and MOGAD: impact on mental health, sleep and quality of lifeEmine Rabia Koc, Furkan Saridas, Mehmet Fatih Yetkin, et al.
Multiple Sclerosis and Related Disorders|February 9, 2024
The role of oligoclonal band count and IgG index in treatment response and disease activity in multiple sclerosisEsra Taşkıran, Murat Terzi, Elif Merve Helvacı, et al.
Noro Psikiyatri Arsivi|March 13, 2023
Clinical and Demographic Characteristics and Two-Year Efficacy and Safety Data of 508 Multiple Sclerosis Patients with Fingolimod TreatmentMurat Terzi, Elif Merve Helvacı, Sedat Şen, et al.
Journal of Neuroimmunology|July 22, 2025
Comparative efficacy of rituximab versus azathioprine in the treatment of MOG antibody-associated disease (MOGAD)Sedat Şen, Murat Kürtüncü, Serkan Demir, et al.
Balkan Medical Journal|June 3, 2024
Clinical, Demographic, and Radiological Characteristics of Patients Demonstrating Antibodies Against Myelin Oligodendrocyte GlycoproteinSümeyye Koç, Sedat Şen, Yüksel Terzi, et al.
Pageof 2